Adult Cognitive DiseaseThe research corpus Monographs

Transcriptional-Epigenetic Dysregulation Node

Progressive gene expression changes that lock in the pathological state, making neurodegeneration self-sustaining.

Converging Mechanisms

  • CREB-mediated transcriptional changes from NMDA hypofunction (Moosmann)
  • HDAC6 upregulation and chromatin remodeling (Rappoport)
  • miRNA dysregulation (miR-134, let-7) affecting spine stability
  • LINE-1 transposable element reactivation
  • Progressive gene expression changes that lock in pathological state

Key Concept

Once transcriptional programs shift, the disease becomes self-reinforcing at the epigenetic level, independent of the original triggers.

To be populated after CSC grading.

See Also

Papers converging on this axis

8
Bess Frost's Chromatin Programme, the Elements It Releases, and the Restraint on cGAS 6 concepts shared Collapse, Traced Cell Type by Cell Type 6 concepts shared Cortical Immature Neurons of Layer II 6 concepts shared The Bredesen ReCODE Protocol Evaluated 6 concepts shared Anatomy of a Neurodegenerative Conduit — The Vagal Interface 5 concepts shared Autophagic Failure as the Convergent Endpoint in Alzheimer's, Parkinson's, ALS and Huntington's 5 concepts shared Beth Stevens's Complement-Pruning Program 5 concepts shared Carlo Abbate's Adult Neurogenesis Theory of Alzheimer's Disease, Critically Evaluated 5 concepts shared

Concepts on this axis

333
Abeta aggregation as necessary initiating eventAcyloxyacyl Hydrolase NeuroprotectionAD as accelerated aging of Abeta managementAD as accelerated normal agingAD as accumulation of insults exceeding homeostasisAD as clinical syndrome not diseaseAD as systemic disease not limited to brainAD caused by APP dysregulation not Abeta per seAdult hippocampal neurogenesis restorationAdult NeurogenesisAge-dependent feedback loops in neurodegenerationAge-related immune dysfunction enables neurotropic virusesAging accelerators and deceleratorsAging as MechanismAging as root cause of ADAging-epigenetic-genetic interactionAI Neurotherapeutic DiscoveryAI-based early diagnosisAluminum as primary environmental causeAluminum driving amyloid productionAmyloid and tau as secondary byproductsAmyloid and tau as secondary phenomenaAmyloid as age-related phenomenonAmyloid as downstream secondaryAmyloid as secondary to synaptic dysfunctionAmyloid clearance as important as depositionAmyloid Clinical DisconnectAmyloid-beta as innate immune defenseAntimicrobial DefenseAntimicrobial hypothesis of amyloidApoE-centric unified modelAPOE4 Pathogen InteractionApoE4 structural vulnerabilityAPP and tau pathology linked through transport disruptionAPP as dependence receptorAstrocyte network management hypothesisAstrocyte-driven amyloid buildupATN biomarker classification systemAutoimmune contribution via BBB compromiseAutoimmune Neurodegeneration

Last reviewed 5 April 2026.

Important noticeThis is a research platform, not a medical site. Nothing here is medical advice, a diagnosis, or a treatment recommendation, and none of it has been reviewed by a regulator. The drugs, doses and trials discussed are research literature, not prescriptions. If dementia affects you or someone you care about, speak to a doctor.

Compiled from the knowledge base and the research corpus under the Organic Network Synthesis methodology · the research corpus of Adult Cognitive Disease · the seven monographs are here. 2026.

854 interlinked articles · 148 papers in full · 53 as typeset PDFs · 635 concepts · 7 convergence nodes · 5 temporal stages.

Discussion

Corrections and disagreements are welcome here, and citation corrections most of all. Posting needs a GitHub account. Please read Taking Part first — in particular, nothing here is medical advice.